Temasek Holdings
GPCR icon

Temasek Holdings’s Structure Therapeutics GPCR Stock Holding History

Temasek Holdings’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,617
Closed -$392K – 104
2023
Q4 		$392K Hold
9,617
– – ﹤0.01% 99
2023
Q3 		$485K Buy
+9,617
New +$310K ﹤0.01% 82

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Temasek Holdings's GPCR Position: Q1 2024 in Review

Temasek Holdings sold out of Structure Therapeutics (GPCR) in Q1 2024, closing a stake of 9,617 shares — an estimated $392K sold.

Temasek Holdings first reported a position in GPCR in Q3 2023 and held it in 2 quarters. The position peaked at $485K in Q3 2023. 119 funds tracked by Wall St. Rank hold GPCR as of Q1 2024.

  • Temasek Holdings reported no remaining Structure Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Temasek Holdings sold 9,617 Structure Therapeutics shares in Q1 2024, an estimated $392K.
  • Temasek Holdings first reported a position in Structure Therapeutics in Q3 2023 and held it in 2 quarters.
  • Temasek Holdings's Structure Therapeutics position peaked at $485K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2024.

Based on Temasek Holdings's 13F filing for Q1 2024, filed 15 May 2024.